Before the Catalogues
Long before a rose appears in a grower’s glossy brochure, before it receives a name registered with the International Cultivar Registration Authority, before it is awarded a gold medal at Chelsea or Baden-Baden, it exists in a twilight world of private exchanges, whispered valuations, and carefully guarded cuttings. This is the pre-commercial rose trade — one of horticulture’s most secretive and stratified markets, operating largely on handshakes, trust, and the quiet prestige of knowing before others know.
This guide is a detailed account of how that world functions: the actors involved, the mechanisms of exchange, the varieties most sought after, and the ethics — often murky — that govern it all.
Part One: The Landscape of Elite Rose Breeding
The Major Breeding Houses
The world’s most exclusive rose varieties originate from a small number of elite breeding programmes, concentrated primarily in France, Germany, the Netherlands, Denmark, and the United Kingdom.
Meilland International (France) is perhaps the most storied house in modern rose breeding. Founded in the early twentieth century and responsible for the legendary ‘Peace’ rose — arguably the most commercially successful rose variety in history — Meilland operates with a degree of mystique that few agricultural enterprises can match. Their breeding programme crosses tens of thousands of seedlings annually, of which only a handful ever reach a commercial licence. The journey from crossing to commercial release routinely spans eight to twelve years.
Kordes Rosen (Germany) has for decades been regarded as the technical pinnacle of rose breeding, particularly in disease resistance and repeat flowering. Their breeding stock is closely controlled and their trial grounds in Klein Offenseth-Sparrieshoop are not open to the public. Kordes are known for releasing varieties only when they meet extremely high thresholds, and the varieties they do release carry enormous commercial weight.
Poulsen Roser (Denmark) introduced the concept of the patio and ground-cover rose to the mass market and continues to produce varieties that combine commercial viability with genuine novelty. Poulsen maintain particularly active licensing relationships with growers across Europe and North America.
David Austin Roses (United Kingdom) occupies a unique position. Founded by the late David Austin, the company popularised the ‘English Rose’ — a re-introduction of Old Rose form combined with modern repeat-flowering genetics. Their releases are among the most anticipated events in the rose world, commanding premium retail pricing and extended waiting lists from both private and trade buyers.
Tantau (Germany) 和 Harkness Roses (United Kingdom) round out the inner circle of elite breeders, each with distinctive genetic lineages and loyal followings among specialist growers.
The Trial System
Before any variety reaches market, it typically undergoes a multi-year trial process. In the United Kingdom, the Royal National Rose Society historically ran trials at their grounds at St Albans, though this function has partially migrated. In continental Europe, the most prestigious trials include those at Bagatelle in Paris, at the Rosarium Uetersen in Germany, and at Westbroekpark in The Hague.
Trial roses are observed across multiple growing seasons for disease resistance, repeat-flowering reliability, weather hardiness, fragrance consistency, and commercial viability. They are given coded names — typically alphanumeric strings — rather than their future commercial names, and access to trial data is tightly restricted.
It is precisely during this trial period that the pre-commercial trade becomes most active.
Part Two: The Actors in the Pre-Commercial Market
The Breeders’ Sales Teams
Each major breeding house employs a small number of highly specialised sales and licensing representatives whose function goes far beyond simple commercial negotiation. These individuals cultivate multi-decade relationships with the world’s top growers, attending the same trade shows (IFTEX in Nairobi, IPM in Essen, the Florint congress circuit), staying at the same hotels, eating at the same dinners. They are gatekeepers of extraordinary power.
Their role in the pre-commercial market is to identify which growers will be granted early access to new varieties — typically through a formal trial licence, which allows a grower to propagate a limited number of plants two to four years before the variety is commercially released. This early access is not offered indiscriminately. It is earned through a history of responsible licensing compliance, volume commitments, geographic exclusivity agreements, and, frankly, personal relationships.
The Elite Licensed Growers
A hierarchy exists among licensed rose growers. At the apex sit perhaps thirty to fifty operations worldwide who are considered the inner circle of the major breeding houses. These include cut-flower producers in Ecuador, Kenya, Ethiopia, and the Netherlands; landscape and garden rose growers in Germany, France, and the UK; and specialty nurseries in North America and Japan.
These growers are distinguished not merely by scale but by reputation. They are known to honour royalty reporting (payment of a per-stem or per-plant fee to the breeder for each propagated plant sold), to adhere to exclusivity clauses, and to present new varieties in a way that enhances rather than diminishes the breeder’s brand. A grower who underpays royalties, or who allows breeders’ material to leave their facility without authorisation, will find themselves quietly removed from the inner circle.
The Plant Hunters and Collectors
Parallel to the formal licensed trade operates a world of private collectors — wealthy individuals, specialist botanical gardens, and rose societies — who acquire unlicensed cuttings through personal relationships with breeders, trial ground employees, or other collectors. This practice exists in a legal grey area at best and outright infringement at worst, but it has a long history in horticulture generally and in roses specifically.
The most sought-after varieties in collector circles are often those that have been discontinued by their breeder, those awaiting formal release, or those that exist only in the collection of a single institution. The value is not commercial — few collectors propagate for sale — but the prestige of growing what no one else has is real, and the informal exchange of cuttings among serious rosarians is an ancient practice.
Rose Society Insiders
National rose societies — the Royal National Rose Society in the UK, the American Rose Society, the Deutsche Rosengesellschaft — serve not only as educational bodies but as social networks that connect breeders, growers, and serious enthusiasts. Senior figures in these societies often have access to trial varieties years before commercial release, through judging roles at trials, consulting relationships with breeders, and personal connections accumulated over careers.
The prestige of being among the first to grow or display a significant new variety is a genuine social currency in this world, and information about upcoming releases is shared — selectively — through these networks.
Part Three: Mechanisms of Exchange
Trial Licences and Letters of Intent
The primary formal mechanism for pre-commercial access is the trial licence. A grower and breeder enter into a contractual agreement allowing the grower to propagate a defined number of plants of an unreleased variety over a defined period, subject to strict conditions: no sale of the variety, no sublicensing, detailed record-keeping, and a commitment to provide the breeder with performance data.
In exchange, growers may be given preferential access to commercial licences upon release, geographic exclusivity for defined markets or territories, and occasionally a royalty reduction reflecting their investment in trialling.
Negotiations for trial licences are often initiated years before a variety is ready. A breeder’s sales representative, attending IPM Essen, may mention to a trusted grower that a particular numbered seedling is “looking very interesting” and ask whether the grower would be positioned to trial it. This is an invitation — carefully calibrated — and the grower’s response begins a negotiation that may span several years.
Letters of intent, while not legally binding in the way formal licences are, are common tools in this period. They signal commitment without locking either party into terms that may need to shift as the variety develops. A well-placed letter of intent can hold a geographic market for a grower against competitors who are also circling.
The Role of Plant Breeders’ Rights
In most major markets, rose varieties can be protected under Plant Breeders’ Rights (PBR) legislation — known in the European Union as Community Plant Variety Rights (CPVR) and in the United States as Plant Patent. These protections give the breeder (or their assignee) the exclusive right to produce and sell propagating material of the variety, typically for twenty to twenty-five years.
PBR applications are generally filed before or coinciding with commercial release, and the process of examination can take one to three years. During this period, the variety is in a protective limbo — not yet formally protected but legally documented as the breeder’s intellectual property. The pre-commercial trade must navigate this carefully: legitimate trial licences granted by the breeder are lawful; any propagation without authorisation is not.
The strategic timing of PBR applications is itself a market signal. When a major breeder files for CPVR protection on a coded variety, attentive observers — lawyers, competing breeders, senior growers — take note. The filing is a matter of public record, accessible via the Community Plant Variety Office database, and a flurry of filings from a single breeder can signal an upcoming release programme.
Private Sales of Breeding Material
At the most rarefied and occasionally legally questionable end of the market sit private sales of breeding material itself — not simply licensed plants, but the genetic stock from which new varieties might be developed. This occurs most commonly when a breeding programme closes, when a breeder retires, or when an estate is liquidated.
Such sales may include seed lots from unreleased crosses, stock plants of numbered seedlings that never reached market, or detailed crossing records that effectively constitute a map of a breeder’s genetic work. The buyers are almost exclusively other breeders, serious collectors, or institutions such as botanical gardens or gene banks. Prices vary enormously and are never made public.
There have been cases — documented in trade litigation and in the horticultural press — where plant material left a breeder’s possession without authorisation and subsequently appeared in commercial programmes under different names. These cases are fiercely contested, legally expensive, and deeply damaging to the reputations of those involved. They are also, in a market as relationship-dependent as this one, career-ending.
Part Four: The Varieties Most Sought After
Characteristics That Drive Pre-Commercial Demand
Not every excellent rose generates pre-commercial excitement. The varieties that do tend to combine several specific characteristics:
Novelty of form or colour. A colour break — a genuinely new hue not previously achieved in roses — creates enormous interest. The development of striped roses, and later of near-black and of truly blue-adjacent roses (the latter still largely unrealised), have each generated intense pre-commercial activity. Equally, a rose that reintroduces Old Rose cupped quartered form with reliable repeat-flowering in a new colour is, in the language of the trade, “a story.”
Disease resistance without sacrificing aesthetics. The commercial pressure to develop roses requiring minimal chemical input has intensified over the past two decades, driven by regulatory changes in the European Union and shifting consumer expectations. A variety that combines genuine black spot resistance with commercial-grade beauty is extraordinarily valuable — and competition among growers to secure early access to such varieties is fierce.
Fragrance. Despite decades of commercial breeding that prioritised shelf life and stem length over scent, fragrance has returned as a primary commercial demand driver, particularly in the garden rose segment. A variety with genuinely exceptional fragrance — not merely detectable, but compelling — commands extraordinary premiums. David Austin’s most celebrated releases have almost invariably been fragrant.
Name and story. The rose trade is as much about narrative as botany. Varieties named for significant cultural figures — royalty, celebrities, historical personages — carry commercial weight that influences pre-commercial competition. Licensing an exclusive regional right to a variety named for a beloved national figure can be transformative for a nursery.
Varieties That Have Generated Particular Pre-Commercial Intensity
Without pretending to completeness — and with the caveat that the most sensitive transactions are by design undocumented — several broad categories deserve mention.
The David Austin English Roses generate, as a class, the most consistently intense pre-commercial competition of any single breeder’s output. The company releases only a small number of new varieties annually, and those releases are preceded by years of trialling during which the varieties are visible at Albrighton but not available. Trade buyers, garden designers, and high-end nurseries jostle for early access, and the company manages this carefully, releasing first to their own garden and mail-order operation before extending licences selectively.
Kordes’ disease-resistant shrub roses have in recent years become the subject of intense interest among public garden managers and landscape contractors, who face the most acute pressure to reduce chemical use. Varieties such as those in the ‘Flower Carpet’ series (technically bred under the Noack programme but indicative of the category’s commercial logic) demonstrated that disease resistance could co-exist with commercial appeal, and any Kordes release perceived to advance this combination generates immediate pre-commercial attention.
Meilland’s cut-flower roses for the Kenya and Ecuador markets are a distinct category, driven by the economics of the industrial cut-flower trade rather than garden aesthetics. Here, pre-commercial interest centres on a specific technical profile: stem length, vase life, production yield per square metre, and cold-chain performance. A variety that materially outperforms the field on these metrics can shift enormous volumes of licensing contracts almost overnight.
Part Five: The Economics
Royalty Structures
Commercial rose licences are almost universally royalty-based. The structure varies by market and negotiation but typically involves a per-plant royalty (for garden and nursery stock) or a per-stem royalty (for cut flowers). Royalties for premium varieties from top breeding houses can be substantial: per-stem royalties of several euro cents, which appear trivial in isolation, aggregate to significant sums across a large commercial operation.
For garden roses from houses such as David Austin or Kordes, per-plant royalties are often supplemented by minimum annual payments that guarantee the breeder a floor of income regardless of the grower’s sales performance. These minima serve simultaneously as revenue protection and as a filter: only growers confident in their ability to sell volume will commit to them.
Pre-commercial trial licences are typically royalty-free or heavily discounted, but they may require the grower to bear propagation costs and to share performance data without compensation. The value to the grower is not immediate financial return but the positional advantage gained by being first to market upon commercial release.
Geographic Exclusivity and Its Premiums
Perhaps the single most valuable commercial instrument in the pre-commercial market is geographic exclusivity — the right to be the sole licensed grower of a variety within a defined territory for a defined period, typically two to five years following commercial release.
Exclusivity premiums are paid as upfront lump sums to the breeder, in addition to ongoing royalties. For a genuinely significant variety — a colour break, a major disease-resistance advance, or a celebrity-named variety in a large market — these premiums can reach six or seven figures in euros or pounds. They are negotiated entirely in private and are never disclosed publicly.
The competition for exclusivity begins during the trial period, sometimes years before the commercial release date is set. A grower who has observed a coded trial variety performing exceptionally well will begin making overtures — through relationship conversations rather than formal proposals — about exclusivity terms. A breeder managing multiple interested parties must balance the financial value of exclusivity premiums against the reputational risk of being seen to favour certain partners unfairly.
Valuing Unreleased Varieties
Determining the value of an unreleased variety is an exercise in informed speculation. The variables are numerous: how does it perform across different climatic zones? Will its colour hold in retail conditions? Is the fragrance consistent across temperatures? Will it receive significant press coverage upon release?
Experienced licensing negotiators on both the breeder and grower sides develop, over careers, a sophisticated intuition for these assessments. They have seen varieties that trialled brilliantly disappoint commercially and others that appeared modest at trial prove transformative in the market. This experiential knowledge is essentially impossible to acquire rapidly and constitutes the primary source of competitive advantage for long-established players.
Part Six: The Social World of the Trade
The Conference Circuit
The major international horticultural trade events are as important as social occasions as they are as commercial marketplaces. IPM Essen in January, IFTEX in Nairobi in June, and the various national rose society conferences are where relationships are maintained, where intelligence is exchanged, and where the pre-commercial trade actually happens — not in formal meetings but in restaurants, hotel bars, and the corridors between trade stands.
Attending these events regularly, over many years, is a prerequisite for participation in the inner market. A grower who disappears from the circuit for several seasons will find on return that they have slipped in the relational hierarchy; conversations that once happened naturally no longer do. The social fabric of the trade is maintained through consistent, visible presence.
The Importance of Discretion
The pre-commercial trade functions on discretion. Growers who discuss their early access to unreleased varieties openly, or who allow information about trial varieties to circulate beyond a trusted circle, find this access revoked. Breeders who leak information about their own programme to generate excitement risk both commercial disadvantage and the particular opprobrium of a community that values confidentiality.
This culture of discretion is not merely strategic; it is also a genuine reflection of the values of an industry that sees itself as a craft tradition rather than a purely commercial one. The leading figures in the rose trade are, for the most part, deeply committed to the plant itself — to its history, its cultural significance, and its future development. The financial dimensions of the pre-commercial market are real, but they exist within a context of genuine horticultural passion that shapes behaviour in ways that purely commercial calculus would not predict.
Trial Gardens and the Protocol of Visiting
The major breeding houses maintain trial grounds that are, in varying degrees, accessible to the trade. Visiting a trial ground is a privilege, and the protocol governing such visits is nuanced. A grower does not simply request a visit; they are invited, and the invitation reflects their standing with the breeder. During a visit, coded trial varieties will be discussed but their numbers and crossing histories will not be shared; questions about release timelines will be answered elliptically, if at all.
Nevertheless, a skilled observer can learn an enormous amount from a trial ground visit: which numbered varieties are receiving the most attention from breeder staff, which are positioned most prominently, which appear repeatedly across multiple trial blocks. This information, combined with knowledge of the breeder’s breeding priorities and market strategies, allows an experienced eye to identify which varieties are likely release candidates — and to begin positioning accordingly.
Part Seven: Ethics and Controversies
Royalty Evasion
The most pervasive ethical problem in the rose trade is royalty evasion — the propagation and sale of protected varieties without payment of the required royalties. This occurs across a wide spectrum of severity, from large-scale deliberate infringement by commercial nurseries (particularly, though not exclusively, in markets where enforcement is difficult) to small-scale propagation by amateur gardeners who may be unaware that the varieties they are growing from cuttings are legally protected.
The consequences for commercial operators caught in deliberate evasion are severe: financial penalties, licence revocations, and permanent exclusion from the breeding houses’ networks. The reputational damage is, in a trade built on relationships, often more devastating than the financial penalties.
Unauthorised Variety Release
Occasionally, a variety reaches the commercial market without the breeder’s authorisation — either through deliberate theft of material or through the honest but legally precarious belief that material acquired informally was freely available. These cases are rare but impactful. When a significant variety appears under a different name in a different market, the subsequent litigation can take years and cost all parties enormously.
The most serious such cases have involved varieties appearing in Asian markets under different names, where enforcement of Plant Breeders’ Rights has historically been challenging. The major breeding houses have invested substantially in recent years in detection mechanisms, including genetic fingerprinting of commercial varieties, and the international enforcement framework has strengthened considerably.
The Question of Genetic Diversity
A more structural concern, less immediately commercial but increasingly recognised, is the effect of the commercial breeding and licensing system on genetic diversity in cultivated roses. The focus of major breeding houses on commercially viable traits — disease resistance, repeat-flowering, production yield — has over generations created a cultivated rose population with a relatively narrow genetic base.
Serious collectors and botanical institutions who maintain collections of species roses, historical varieties, and obscure regional cultivars serve a vital conservation function. The pre-commercial exchange networks among this collector community, which overlap but are not identical to the commercial trade, preserve genetic material that commercial breeders increasingly recognise as potentially valuable for future breeding work.
Access as Currency
The pre-commercial rose trade is, at its core, a system in which access is the primary currency. Access to the inner circle of breeding houses. Access to trial grounds. Access to coded variety numbers before the rest of the trade. Access to the conversations in which genuine decisions are made.
This access is earned slowly, through decades of reliable behaviour, substantial financial commitment, and the cultivation of personal relationships with individuals who are themselves deeply embedded in the trade’s social fabric. It cannot be purchased directly, though money is certainly part of the equation. It cannot be acquired quickly. And once lost — through a reputation for royalty evasion, indiscretion, or contractual unreliability — it is almost impossible to recover.
The varieties that emerge from this system — the great Meilland releases, the David Austin icons, the Kordes disease-resistant breakthroughs — carry within their petals the accumulated decisions of this invisible market: who was trusted, who was first, who paid what for the right to grow a flower that did not yet have a name.
For those who know the world well enough to navigate it, there is no more fascinating market in horticulture. For those on the outside, it remains what the best roses always have been — beautiful, desirable, and just out of reach.
0 responses to “The Shadow Market of Elite Roses: A Guide to the Pre-Commercial Trade in the World’s Most Exclusive Varieties”